KR930007580B1 - 유두종 비루스 게놈으로부터 유도된 결정 dna 서열, 그의 시험관내 진단 목적용 용도 및 항원 조성물의 제조 방법 - Google Patents
유두종 비루스 게놈으로부터 유도된 결정 dna 서열, 그의 시험관내 진단 목적용 용도 및 항원 조성물의 제조 방법 Download PDFInfo
- Publication number
 - KR930007580B1 KR930007580B1 KR1019870701075A KR870701075A KR930007580B1 KR 930007580 B1 KR930007580 B1 KR 930007580B1 KR 1019870701075 A KR1019870701075 A KR 1019870701075A KR 870701075 A KR870701075 A KR 870701075A KR 930007580 B1 KR930007580 B1 KR 930007580B1
 - Authority
 - KR
 - South Korea
 - Prior art keywords
 - dna
 - hpv
 - recombinant
 - sequence
 - papilloma virus
 - Prior art date
 - Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
 - Expired - Lifetime
 
Links
- 238000000034 method Methods 0.000 title claims description 18
 - 241001631646 Papillomaviridae Species 0.000 title description 21
 - 108091028043 Nucleic acid sequence Proteins 0.000 title description 20
 - 238000000338 in vitro Methods 0.000 title description 4
 - 239000000203 mixture Substances 0.000 title description 4
 - 239000000427 antigen Substances 0.000 title 1
 - 102000036639 antigens Human genes 0.000 title 1
 - 108091007433 antigens Proteins 0.000 title 1
 - 108020004414 DNA Proteins 0.000 claims description 34
 - 108090000623 proteins and genes Proteins 0.000 claims description 25
 - 102000004169 proteins and genes Human genes 0.000 claims description 22
 - 125000003729 nucleotide group Chemical group 0.000 claims description 20
 - 108090000765 processed proteins & peptides Proteins 0.000 claims description 20
 - 239000002773 nucleotide Substances 0.000 claims description 18
 - 239000000523 sample Substances 0.000 claims description 15
 - 239000013598 vector Substances 0.000 claims description 12
 - 238000009396 hybridization Methods 0.000 claims description 10
 - 108700026244 Open Reading Frames Proteins 0.000 claims description 9
 - 239000012634 fragment Substances 0.000 claims description 9
 - 238000004519 manufacturing process Methods 0.000 claims description 5
 - 241000588724 Escherichia coli Species 0.000 claims description 3
 - 108020004511 Recombinant DNA Proteins 0.000 claims 5
 - 241000894006 Bacteria Species 0.000 claims 2
 - 108020005202 Viral DNA Proteins 0.000 claims 2
 - 238000003780 insertion Methods 0.000 claims 1
 - 230000037431 insertion Effects 0.000 claims 1
 - 208000022361 Human papillomavirus infectious disease Diseases 0.000 description 37
 - 102000004196 processed proteins & peptides Human genes 0.000 description 16
 - 241000700605 Viruses Species 0.000 description 14
 - 241000701806 Human papillomavirus Species 0.000 description 13
 - 241000341655 Human papillomavirus type 16 Species 0.000 description 13
 - 229920001184 polypeptide Polymers 0.000 description 13
 - 210000004027 cell Anatomy 0.000 description 12
 - 239000003623 enhancer Substances 0.000 description 11
 - 238000001514 detection method Methods 0.000 description 10
 - 108091092724 Noncoding DNA Proteins 0.000 description 7
 - 238000013518 transcription Methods 0.000 description 6
 - 230000035897 transcription Effects 0.000 description 6
 - 206010028980 Neoplasm Diseases 0.000 description 5
 - 230000014509 gene expression Effects 0.000 description 5
 - 241000388186 Deltapapillomavirus 4 Species 0.000 description 4
 - 108091027569 Z-DNA Proteins 0.000 description 4
 - 230000001105 regulatory effect Effects 0.000 description 4
 - 230000010076 replication Effects 0.000 description 4
 - 238000013519 translation Methods 0.000 description 4
 - QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
 - 238000001712 DNA sequencing Methods 0.000 description 3
 - 238000004458 analytical method Methods 0.000 description 3
 - 238000001574 biopsy Methods 0.000 description 3
 - 238000010367 cloning Methods 0.000 description 3
 - 210000003527 eukaryotic cell Anatomy 0.000 description 3
 - 210000004392 genitalia Anatomy 0.000 description 3
 - 239000000463 material Substances 0.000 description 3
 - 230000002246 oncogenic effect Effects 0.000 description 3
 - 239000013612 plasmid Substances 0.000 description 3
 - 230000008488 polyadenylation Effects 0.000 description 3
 - 238000012552 review Methods 0.000 description 3
 - 206010008342 Cervix carcinoma Diseases 0.000 description 2
 - HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
 - 108091026890 Coding region Proteins 0.000 description 2
 - 108020004705 Codon Proteins 0.000 description 2
 - 230000006820 DNA synthesis Effects 0.000 description 2
 - LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
 - 241001465754 Metazoa Species 0.000 description 2
 - 239000000020 Nitrocellulose Substances 0.000 description 2
 - 241000283973 Oryctolagus cuniculus Species 0.000 description 2
 - 108091081062 Repeated sequence (DNA) Proteins 0.000 description 2
 - 101710172711 Structural protein Proteins 0.000 description 2
 - 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 2
 - 230000004913 activation Effects 0.000 description 2
 - 239000002585 base Substances 0.000 description 2
 - 230000015572 biosynthetic process Effects 0.000 description 2
 - 201000010881 cervical cancer Diseases 0.000 description 2
 - 230000000052 comparative effect Effects 0.000 description 2
 - 230000000295 complement effect Effects 0.000 description 2
 - 238000004925 denaturation Methods 0.000 description 2
 - 230000036425 denaturation Effects 0.000 description 2
 - 201000010099 disease Diseases 0.000 description 2
 - 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
 - 230000002068 genetic effect Effects 0.000 description 2
 - 230000001900 immune effect Effects 0.000 description 2
 - 230000003902 lesion Effects 0.000 description 2
 - 239000002609 medium Substances 0.000 description 2
 - 229920001220 nitrocellulos Polymers 0.000 description 2
 - 231100000590 oncogenic Toxicity 0.000 description 2
 - 238000002360 preparation method Methods 0.000 description 2
 - 230000002285 radioactive effect Effects 0.000 description 2
 - 108091008146 restriction endonucleases Proteins 0.000 description 2
 - 238000012163 sequencing technique Methods 0.000 description 2
 - 230000009385 viral infection Effects 0.000 description 2
 - 230000003612 virological effect Effects 0.000 description 2
 - 108010032595 Antibody Binding Sites Proteins 0.000 description 1
 - 241000283690 Bos taurus Species 0.000 description 1
 - 108020004638 Circular DNA Proteins 0.000 description 1
 - 101150029662 E1 gene Proteins 0.000 description 1
 - 241000201835 Froelichia floridana Species 0.000 description 1
 - 108700028146 Genetic Enhancer Elements Proteins 0.000 description 1
 - 108091027305 Heteroduplex Proteins 0.000 description 1
 - 241000701044 Human gammaherpesvirus 4 Species 0.000 description 1
 - 241000829111 Human polyomavirus 1 Species 0.000 description 1
 - 206010064912 Malignant transformation Diseases 0.000 description 1
 - 108020004485 Nonsense Codon Proteins 0.000 description 1
 - 108091034117 Oligonucleotide Proteins 0.000 description 1
 - 241000700159 Rattus Species 0.000 description 1
 - 108020005091 Replication Origin Proteins 0.000 description 1
 - 206010039491 Sarcoma Diseases 0.000 description 1
 - 108700029229 Transcriptional Regulatory Elements Proteins 0.000 description 1
 - 108010067390 Viral Proteins Proteins 0.000 description 1
 - 208000036142 Viral infection Diseases 0.000 description 1
 - JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 1
 - 238000005299 abrasion Methods 0.000 description 1
 - 230000009471 action Effects 0.000 description 1
 - 238000000246 agarose gel electrophoresis Methods 0.000 description 1
 - 239000003513 alkali Substances 0.000 description 1
 - 238000003556 assay Methods 0.000 description 1
 - 239000013060 biological fluid Substances 0.000 description 1
 - 201000011510 cancer Diseases 0.000 description 1
 - 210000000234 capsid Anatomy 0.000 description 1
 - 210000002421 cell wall Anatomy 0.000 description 1
 - 208000019065 cervical carcinoma Diseases 0.000 description 1
 - 125000003636 chemical group Chemical group 0.000 description 1
 - 230000021615 conjugation Effects 0.000 description 1
 - 125000004122 cyclic group Chemical group 0.000 description 1
 - 230000001419 dependent effect Effects 0.000 description 1
 - 238000000151 deposition Methods 0.000 description 1
 - 238000011161 development Methods 0.000 description 1
 - 238000002405 diagnostic procedure Methods 0.000 description 1
 - 108010052305 exodeoxyribonuclease III Proteins 0.000 description 1
 - 238000002474 experimental method Methods 0.000 description 1
 - 239000001963 growth medium Substances 0.000 description 1
 - 210000004408 hybridoma Anatomy 0.000 description 1
 - 230000008696 hypoxemic pulmonary vasoconstriction Effects 0.000 description 1
 - 238000001727 in vivo Methods 0.000 description 1
 - 230000036212 malign transformation Effects 0.000 description 1
 - 230000003211 malignant effect Effects 0.000 description 1
 - 210000004962 mammalian cell Anatomy 0.000 description 1
 - 244000005700 microbiome Species 0.000 description 1
 - 230000004048 modification Effects 0.000 description 1
 - 238000012986 modification Methods 0.000 description 1
 - 238000002715 modification method Methods 0.000 description 1
 - 238000010369 molecular cloning Methods 0.000 description 1
 - 238000002703 mutagenesis Methods 0.000 description 1
 - 231100000350 mutagenesis Toxicity 0.000 description 1
 - 210000000496 pancreas Anatomy 0.000 description 1
 - 239000012188 paraffin wax Substances 0.000 description 1
 - 230000003389 potentiating effect Effects 0.000 description 1
 - 210000001236 prokaryotic cell Anatomy 0.000 description 1
 - 230000035755 proliferation Effects 0.000 description 1
 - 238000000746 purification Methods 0.000 description 1
 - 230000008439 repair process Effects 0.000 description 1
 - 230000003362 replicative effect Effects 0.000 description 1
 - 238000011160 research Methods 0.000 description 1
 - 230000004044 response Effects 0.000 description 1
 - 238000000926 separation method Methods 0.000 description 1
 - 210000002966 serum Anatomy 0.000 description 1
 - 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 1
 - 238000010561 standard procedure Methods 0.000 description 1
 - 238000006467 substitution reaction Methods 0.000 description 1
 - 230000004083 survival effect Effects 0.000 description 1
 - 230000002889 sympathetic effect Effects 0.000 description 1
 - 238000003786 synthesis reaction Methods 0.000 description 1
 - 108091006106 transcriptional activators Proteins 0.000 description 1
 - 238000012546 transfer Methods 0.000 description 1
 - 230000009466 transformation Effects 0.000 description 1
 - 231100000588 tumorigenic Toxicity 0.000 description 1
 - 230000000381 tumorigenic effect Effects 0.000 description 1
 - 210000003501 vero cell Anatomy 0.000 description 1
 - 230000006490 viral transcription Effects 0.000 description 1
 - 238000001262 western blot Methods 0.000 description 1
 - 210000005253 yeast cell Anatomy 0.000 description 1
 
Images
Classifications
- 
        
- C—CHEMISTRY; METALLURGY
 - C07—ORGANIC CHEMISTRY
 - C07K—PEPTIDES
 - C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
 - C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
 
 - 
        
- A—HUMAN NECESSITIES
 - A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
 - A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
 - A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
 - A61P31/12—Antivirals
 
 - 
        
- A—HUMAN NECESSITIES
 - A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
 - A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
 - A61P37/00—Drugs for immunological or allergic disorders
 - A61P37/02—Immunomodulators
 - A61P37/04—Immunostimulants
 
 - 
        
- C—CHEMISTRY; METALLURGY
 - C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
 - C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
 - C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
 
 - 
        
- C—CHEMISTRY; METALLURGY
 - C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
 - C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
 - C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
 - C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
 - C12Q1/701—Specific hybridization probes
 - C12Q1/708—Specific hybridization probes for papilloma
 
 - 
        
- A—HUMAN NECESSITIES
 - A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
 - A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
 - A61K39/00—Medicinal preparations containing antigens or antibodies
 
 - 
        
- C—CHEMISTRY; METALLURGY
 - C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
 - C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
 - C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
 - C12N2710/00011—Details
 - C12N2710/20011—Papillomaviridae
 - C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
 
 
Landscapes
- Health & Medical Sciences (AREA)
 - Chemical & Material Sciences (AREA)
 - Life Sciences & Earth Sciences (AREA)
 - Organic Chemistry (AREA)
 - Engineering & Computer Science (AREA)
 - Immunology (AREA)
 - Genetics & Genomics (AREA)
 - General Health & Medical Sciences (AREA)
 - Zoology (AREA)
 - Wood Science & Technology (AREA)
 - Bioinformatics & Cheminformatics (AREA)
 - Virology (AREA)
 - Proteomics, Peptides & Aminoacids (AREA)
 - Medicinal Chemistry (AREA)
 - Biochemistry (AREA)
 - Biotechnology (AREA)
 - Molecular Biology (AREA)
 - Microbiology (AREA)
 - General Engineering & Computer Science (AREA)
 - Biophysics (AREA)
 - Pharmacology & Pharmacy (AREA)
 - Veterinary Medicine (AREA)
 - Physics & Mathematics (AREA)
 - Biomedical Technology (AREA)
 - Gastroenterology & Hepatology (AREA)
 - Chemical Kinetics & Catalysis (AREA)
 - General Chemical & Material Sciences (AREA)
 - Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
 - Analytical Chemistry (AREA)
 - Animal Behavior & Ethology (AREA)
 - Public Health (AREA)
 - Oncology (AREA)
 - Communicable Diseases (AREA)
 - Peptides Or Proteins (AREA)
 - Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
 - Preparation Of Compounds By Using Micro-Organisms (AREA)
 - Micro-Organisms Or Cultivation Processes Thereof (AREA)
 - Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
 - Saccharide Compounds (AREA)
 - Investigating Or Analysing Biological Materials (AREA)
 
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title | 
|---|---|---|---|
| EP86400609.3 | 1986-03-21 | ||
| EP86400609 | 1986-03-21 | ||
| PCT/EP1987/000158 WO1987005630A1 (en) | 1986-03-21 | 1987-03-20 | Determined dna sequences derived from a papillomavirus genome, their uses for in vitro diagnostic purposes and the production of antigenic compositions | 
Publications (1)
| Publication Number | Publication Date | 
|---|---|
| KR930007580B1 true KR930007580B1 (ko) | 1993-08-13 | 
Family
ID=8196291
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date | 
|---|---|---|---|
| KR1019870701075A Expired - Lifetime KR930007580B1 (ko) | 1986-03-21 | 1987-03-20 | 유두종 비루스 게놈으로부터 유도된 결정 dna 서열, 그의 시험관내 진단 목적용 용도 및 항원 조성물의 제조 방법 | 
Country Status (13)
Families Citing this family (52)
| Publication number | Priority date | Publication date | Assignee | Title | 
|---|---|---|---|---|
| US5876922A (en) | 1985-07-31 | 1999-03-02 | Institute Pasteur | Papillomavirus probe and a process for in vitro diagnosis of papillomavirus infections | 
| WO1987005630A1 (en) * | 1986-03-21 | 1987-09-24 | Institut Pasteur | Determined dna sequences derived from a papillomavirus genome, their uses for in vitro diagnostic purposes and the production of antigenic compositions | 
| US4777239A (en) * | 1986-07-10 | 1988-10-11 | The Board Of Trustees Of The Leland Stanford Junior University | Diagnostic peptides of human papilloma virus | 
| FR2629458B2 (fr) * | 1987-07-31 | 1991-08-09 | Ire Celltarg Sa | Nouvelles sondes d'acides nucleiques specifiques de differents types de virus de papillome humain | 
| EP0408658A4 (en) * | 1988-04-04 | 1991-10-02 | Oncor, Inc. | Human papilloma virus typing method and nucleic acid probes used therein | 
| FR2631341B1 (fr) * | 1988-05-13 | 1991-04-26 | Pasteur Institut | Sondes a papillomavirus hpv49, hpv50, hpv54, hpv55 et produits genetiquement et immunologiquement lies a ce papillomavirus hpv49, hpv50, hpv54, hpv55 et procede de diagnostic in vitro d'infections a papillomavirus et d'immunisation in vivo contre ces papillomavirus | 
| FR2632956B2 (fr) * | 1988-05-13 | 1991-07-12 | Pasteur Institut | Sondes a papillomavirus hpv49, hpv50, hpv54, hpv55; produits genetiquement et immunologiquement lies a ce papillomavirus hpv49, hpv50, hpv54, hpv55; procede de diagnostic in vitro d'infections a papillomavirus et d'immunisation in vivo contre ces papillomavirus | 
| CA1339729C (en) * | 1988-10-26 | 1998-03-17 | Wayne D. Lancaster | Human papillomavirus type 52 dna sequences and methods for employing thesame | 
| SE8803870D0 (sv) * | 1988-10-28 | 1988-10-28 | Medscand Ab | Method for detection of human papillomavirus (hpv) for diagnostic purposes | 
| DE3838269A1 (de) * | 1988-11-11 | 1990-05-17 | Behringwerke Ag | Nachweis humaner papillomavirus dna und ihrer expression in zervix-abstrichen | 
| EP0662518B1 (en) * | 1989-12-01 | 2001-11-07 | VYSIS, Inc. | Nucleic acid probes for detection of HPV transcripts | 
| US5580970A (en) * | 1989-12-01 | 1996-12-03 | Amoco Corporation | Detection of HPV transcripts | 
| FR2656627B1 (fr) * | 1989-12-28 | 1992-04-17 | Pasteur Institut | Sonde a papillomavirus (hvpv63), notamment pour le diagnostic in vitro d'infections a papillomavirus, pouvant s'accompagner de neoplasies genitales, et produits genetiquement et immunologiquement lies a ce papillomavirus. | 
| US5932412A (en) * | 1990-05-11 | 1999-08-03 | Euro-Diagnostica Ab | Synthetic peptides in human papillomaviruses 1, 5, 6, 8, 11, 16, 18, 31, 33 and 56, useful in immunoassay for diagnostic purposes | 
| SE9001705D0 (sv) * | 1990-05-11 | 1990-05-11 | Medscand Ab | Saett foer diagnostik av virusbaerande tumoerer genom immunoassay | 
| CA2052413C (en) * | 1990-09-28 | 2004-07-13 | Jeffrey L. Joseph | Nucleotides sequences useful as type-specific probes, pcr primers and lcr probes for the amplifications and detection of human papilloma virus, and related kits and methods | 
| US6013258A (en) * | 1997-10-09 | 2000-01-11 | Zycos Inc. | Immunogenic peptides from the HPV E7 protein | 
| US6183746B1 (en) | 1997-10-09 | 2001-02-06 | Zycos Inc. | Immunogenic peptides from the HPV E7 protein | 
| US7569344B2 (en) * | 1998-10-26 | 2009-08-04 | Ventana Medical Systems, Inc. | Detection of human papilloma virus in papanicolaou (Pap) smears | 
| AU778737B2 (en) * | 1999-04-14 | 2004-12-16 | Musc Foundation For Research Development | Tissue-specific and pathogen-specific toxic agents and ribozymes | 
| US20050100928A1 (en) * | 1999-09-16 | 2005-05-12 | Zycos Inc., A Delaware Corporation | Nucleic acids encoding polyepitope polypeptides | 
| US20060275784A1 (en) * | 1999-10-26 | 2006-12-07 | Ventana Medical Systems, Inc. | Detection of Human Papilloma Virus in Papanicolaou (Pap) Smears | 
| AU2001256976A1 (en) * | 2000-04-03 | 2001-10-15 | Cytyc Corporation | Detection and typing of human papillomavirus using pna probes | 
| US6936443B2 (en) * | 2000-04-03 | 2005-08-30 | Cytyc Corporation | Detection and typing of human papillomavirus using PNA probes | 
| US20040229298A1 (en) * | 2000-11-11 | 2004-11-18 | Lu Peter S. | Methods and compositions for treating cervical cancer | 
| US7312041B2 (en) * | 2001-02-16 | 2007-12-25 | Arbor Vita Corporation | Methods of diagnosing cervical cancer | 
| US20030059806A1 (en) * | 2001-01-05 | 2003-03-27 | Science & Technology Corporation @ Unm | Probes for the detection of human papillomavirus | 
| EP2272988A3 (en) | 2002-01-07 | 2011-06-15 | Norchip A/S | Method for detecting human papillomavirus mRNA | 
| HUP0200981A3 (en) | 2002-03-14 | 2004-06-28 | Genoid Kft | Pcr reactions with hybridizing probes using primers with broad genotype-specificity for detection of human papilloma-viruses and typing amplificates by using specifically hybridizing oligonucleotides | 
| US7704965B2 (en) * | 2002-06-26 | 2010-04-27 | The Penn State Research Foundation | Methods and materials for treating human papillomavirus infections | 
| DE60325382D1 (de) | 2002-09-09 | 2009-01-29 | Arbor Vita Corp | Verfahren zur diagnose von gebärmutterhalskrebs | 
| WO2004037175A2 (en) * | 2002-10-21 | 2004-05-06 | Mgi Pharma Biologics, Inc. | Compositions and methods for treating human papillomavirus-mediated disease | 
| AU2004275865B2 (en) | 2003-09-25 | 2008-09-25 | Third Wave Technologies, Inc. | Detection of HPV | 
| AU2004308964B2 (en) * | 2003-12-23 | 2010-09-16 | Arbor Vita Corporation | Antibodies for oncogenic strains of HPV and methods of their use | 
| CA2588581C (en) | 2004-12-08 | 2011-05-31 | Gen-Probe Incorporated | Detection of nucleic acids from multiple types of human papillomaviruses | 
| EP1833985B1 (en) * | 2004-12-10 | 2014-08-27 | Genera Biosystems Limited | Human papilloma virus (hpv) detection using nucleic acid probes, microbeads and fluorescent-activated cell sorter (facs) | 
| EP1853307B1 (en) | 2005-02-01 | 2016-12-14 | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, the Department of Health and Human Services, | Papillomavirus L2 N-terminal peptides for the induction of broadly cross-neutralizing antibodies | 
| US20070031826A1 (en) * | 2005-08-05 | 2007-02-08 | My Gene | Diagnostic kit for determining the genotype of a human papilloma virus and method of using thereof | 
| US7972776B2 (en) * | 2005-11-15 | 2011-07-05 | Oncohealth Corporation | Protein chips for HPV detection | 
| US7732166B2 (en) * | 2005-11-15 | 2010-06-08 | Oncohealth Corporation | Detection method for human pappilomavirus (HPV) and its application in cervical cancer | 
| US8080643B2 (en) * | 2006-09-05 | 2011-12-20 | Third Wave Technologies, Inc. | HPV primers | 
| US20100003704A1 (en) | 2008-06-13 | 2010-01-07 | Shuling Cheng | IN SITU detection of early stages and late stages HPV infection | 
| US8968995B2 (en) * | 2008-11-12 | 2015-03-03 | Oncohealth Corp. | Detection, screening, and diagnosis of HPV-associated cancers | 
| AU2008236678B2 (en) * | 2007-04-05 | 2013-09-12 | Genera Biosystems Limited | Compositions and methods of detection | 
| US8980562B1 (en) | 2007-06-12 | 2015-03-17 | Physicians Reference Laboratory | Method of simultaneous detection and typing of human papilloma viruses | 
| JP2012526286A (ja) | 2009-05-07 | 2012-10-25 | オンコヘルス コーポレーション | ヒトパピローマウイルス(hpv)およびhpv関連癌の初期段階および後期段階の検出、スクリーニング、および診断のための高度または≧cin2の同定 | 
| JP5819851B2 (ja) | 2010-01-08 | 2015-11-24 | オンコヘルス コーポレーション | Hpv関連の癌の治療及びスクリーニングのための細胞に基づいた高処理能力hpv免疫アッセイ | 
| AU2011210748A1 (en) | 2010-01-29 | 2012-08-09 | Qiagen Gaithersburg, Inc. | Method of determining and confirming the presence of HPV in a sample | 
| JP6153866B2 (ja) | 2010-05-25 | 2017-06-28 | キアゲン ガイサーズバーグ アイエヌシー. | 迅速なハイブリッド捕捉アッセイ、及び関連する戦略的に切断されたプローブ | 
| CN102229660B (zh) * | 2011-05-25 | 2015-04-22 | 厦门大学 | 截短的人乳头瘤病毒33型l1蛋白 | 
| CN104076150A (zh) * | 2013-03-28 | 2014-10-01 | 沈萍萍 | 一种hpv-e6蛋白的检测方法 | 
| US9936943B1 (en) | 2014-08-07 | 2018-04-10 | Nicholas MANCINI | Suture passing surgical device with atraumatic grasper preventing accidental perforations | 
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title | 
|---|---|---|---|---|
| US4358535A (en) * | 1980-12-08 | 1982-11-09 | Board Of Regents Of The University Of Washington | Specific DNA probes in diagnostic microbiology | 
| US4419446A (en) * | 1980-12-31 | 1983-12-06 | The United States Of America As Represented By The Department Of Health And Human Services | Recombinant DNA process utilizing a papilloma virus DNA as a vector | 
| FR2524487B1 (fr) * | 1982-04-05 | 1985-11-22 | Pasteur Institut | Fragments d'adn codant pour des polypeptides contenant au moins un determinant antigenique des papillomavirus, notamment du type hpv 1a et polypeptides correspondants | 
| JPS6089755A (ja) * | 1983-07-01 | 1985-05-20 | フイリツプ・ジヨン・ベア−ド | 診断用試薬及びその製造法並びにそれを用いる診断法 | 
| US5411857A (en) * | 1985-07-31 | 1995-05-02 | Institut Nationale De La Sante | Probes for papillomaviruses and an in vitro diagnostic procedure for papilloma infections | 
| CA1276575C (fr) * | 1984-11-30 | 1990-11-20 | Sylvie Beaudenon | Sondes a papillomavirus et procede de diagnostic in vitro d'infections a papillomavirus | 
| EP0217919B1 (en) * | 1985-04-04 | 1992-08-05 | Georgetown University | Type-specific papillomavirus dna sequences and peptides | 
| FR2586428B1 (fr) * | 1985-08-26 | 1988-11-25 | Pasteur Institut | Polypeptides et anticorps, caracteristiques du papillomavirus et leurs applications au diagnostic in vitro, a la prevention et/ou la lutte contre des infections a papillomavirus | 
| WO1987005630A1 (en) * | 1986-03-21 | 1987-09-24 | Institut Pasteur | Determined dna sequences derived from a papillomavirus genome, their uses for in vitro diagnostic purposes and the production of antigenic compositions | 
| US4849322A (en) * | 1986-04-30 | 1989-07-18 | E. I. Du Pont De Nemours And Company | Positive-working color proofing film and process | 
| DE3625257A1 (de) * | 1986-07-23 | 1988-02-04 | Behringwerke Ag | Expressionsprodukte der menschlichen papillomviren typ 16 und 18, fuer diese proteine spezifische antikoerper und diese antikoerper bzw. entsprechende dna enthaltende diagnostika | 
| US4849331A (en) * | 1987-06-09 | 1989-07-18 | Life Technologies, Inc. | Human papillomavirus 44 nucleic acid hybridization probes and methods for employing the same | 
| US4849334A (en) * | 1987-06-09 | 1989-07-18 | Life Technologies, Inc. | Human papillomavirus 43 nucleic acid hybridization probes and methods for employing the same | 
| US4849332A (en) * | 1987-05-26 | 1989-07-18 | Life Technologies, Inc. | Human papillomavirus 35 nucleic acid hybridization probes and methods for employing the same | 
| DE3722967A1 (de) * | 1987-07-11 | 1989-01-19 | Behringwerke Ag | Monoklonale antikoerper gegen e7-protein des humanen papillomvirus typ 16, verfahren zu ihrer herstellung sowie ihre verwendung | 
| FR2629458B2 (fr) * | 1987-07-31 | 1991-08-09 | Ire Celltarg Sa | Nouvelles sondes d'acides nucleiques specifiques de differents types de virus de papillome humain | 
| US5182377A (en) * | 1988-09-09 | 1993-01-26 | Hoffmann-La Roche Inc. | Probes for detection of human papillomavirus | 
| DE3935592A1 (de) * | 1989-10-26 | 1991-05-02 | Hella Kg Hueck & Co | Verfahren und einrichtung zur regelung der innenraumtemperatur von kraftfahrzeugen | 
| EP0662518B1 (en) * | 1989-12-01 | 2001-11-07 | VYSIS, Inc. | Nucleic acid probes for detection of HPV transcripts | 
| FR2663040B1 (fr) * | 1990-06-11 | 1995-09-15 | Bio Merieux | Procede de detection d'une sequence nucleotidique selon la technique d'hybridation sandwich. | 
| CA2052413C (en) * | 1990-09-28 | 2004-07-13 | Jeffrey L. Joseph | Nucleotides sequences useful as type-specific probes, pcr primers and lcr probes for the amplifications and detection of human papilloma virus, and related kits and methods | 
| IT1244462B (it) * | 1990-12-06 | 1994-07-15 | Sclavo Spa | Oligonucleotidi sintetici utili per la diagnosi di infezione da tipi diversi di virus del gruppo papilloma e loro utilizzazione | 
- 
        1987
        
- 1987-03-20 WO PCT/EP1987/000158 patent/WO1987005630A1/en active IP Right Grant
 - 1987-03-20 ES ES87400635T patent/ES2039254T3/es not_active Expired - Lifetime
 - 1987-03-20 EP EP87400635A patent/EP0243221B1/en not_active Expired - Lifetime
 - 1987-03-20 JP JP62501988A patent/JP2633275B2/ja not_active Expired - Lifetime
 - 1987-03-20 AT AT87400635T patent/ATE76429T1/de not_active IP Right Cessation
 - 1987-03-20 DE DE8787400635T patent/DE3779175D1/de not_active Expired - Lifetime
 - 1987-03-20 AU AU72007/87A patent/AU615159B2/en not_active Expired
 - 1987-03-20 KR KR1019870701075A patent/KR930007580B1/ko not_active Expired - Lifetime
 - 1987-11-13 NO NO874750A patent/NO303287B1/no unknown
 - 1987-11-17 FI FI875082A patent/FI100057B/fi not_active IP Right Cessation
 - 1987-11-18 DK DK198706059A patent/DK175314B1/da not_active IP Right Cessation
 
 - 
        1992
        
- 1992-07-28 GR GR920401601T patent/GR3005272T3/el unknown
 
 - 
        1994
        
- 1994-03-25 US US08/222,569 patent/US5554538A/en not_active Expired - Lifetime
 
 - 
        1995
        
- 1995-06-06 US US08/466,711 patent/US5648459A/en not_active Expired - Lifetime
 
 - 
        1996
        
- 1996-10-16 JP JP8273824A patent/JP2735537B2/ja not_active Expired - Lifetime
 
 - 
        1997
        
- 1997-07-15 US US08/891,801 patent/US5876723A/en not_active Expired - Lifetime
 
 - 
        1999
        
- 1999-06-11 US US09/330,076 patent/US6107086A/en not_active Expired - Fee Related
 
 - 
        2000
        
- 2000-05-25 US US09/577,493 patent/US6242250B1/en not_active Expired - Fee Related
 
 - 
        2001
        
- 2001-04-12 US US09/832,852 patent/US6344314B2/en not_active Expired - Fee Related
 
 - 
        2003
        
- 2003-10-22 US US10/691,776 patent/US7063963B2/en not_active Expired - Fee Related
 
 
Also Published As
| Publication number | Publication date | 
|---|---|
| AU7200787A (en) | 1987-10-09 | 
| DK605987D0 (da) | 1987-11-18 | 
| WO1987005630A1 (en) | 1987-09-24 | 
| DK605987A (da) | 1987-11-18 | 
| AU615159B2 (en) | 1991-09-26 | 
| JPH09117294A (ja) | 1997-05-06 | 
| US5554538A (en) | 1996-09-10 | 
| US7063963B2 (en) | 2006-06-20 | 
| US20040132012A1 (en) | 2004-07-08 | 
| US6242250B1 (en) | 2001-06-05 | 
| NO874750D0 (no) | 1987-11-13 | 
| NO874750L (no) | 1987-11-13 | 
| US6107086A (en) | 2000-08-22 | 
| US5648459A (en) | 1997-07-15 | 
| US20010049137A1 (en) | 2001-12-06 | 
| FI875082A0 (fi) | 1987-11-17 | 
| GR3005272T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1993-05-24 | 
| FI100057B (fi) | 1997-09-15 | 
| JPS63502798A (ja) | 1988-10-20 | 
| ATE76429T1 (de) | 1992-06-15 | 
| EP0243221B1 (en) | 1992-05-20 | 
| DK175314B1 (da) | 2004-08-16 | 
| US5876723A (en) | 1999-03-02 | 
| ES2039254T3 (es) | 1995-04-01 | 
| EP0243221A1 (en) | 1987-10-28 | 
| DE3779175D1 (de) | 1992-06-25 | 
| FI875082A7 (fi) | 1987-11-17 | 
| JP2735537B2 (ja) | 1998-04-02 | 
| US6344314B2 (en) | 2002-02-05 | 
| JP2633275B2 (ja) | 1997-07-23 | 
| NO303287B1 (no) | 1998-06-22 | 
Similar Documents
| Publication | Publication Date | Title | 
|---|---|---|
| KR930007580B1 (ko) | 유두종 비루스 게놈으로부터 유도된 결정 dna 서열, 그의 시험관내 진단 목적용 용도 및 항원 조성물의 제조 방법 | |
| Cole et al. | Genome organization and nucleotide sequence of human papillomavirus type 33, which is associated with cervical cancer | |
| JP2872582B2 (ja) | 型特異的乳頭腫ウイルスdna配列およびペプチド | |
| Seif et al. | The genome of human papovavirus BKV | |
| KR0164215B1 (ko) | 사람 유두종바이러스 제16형 e7 단백질상의 면역원성 서열을 갖는 폴리펩타이드 | |
| JP3207389B2 (ja) | 乳頭腫ウィルス及びその診断方法 | |
| KR970703425A (ko) | G형 간염 바이러스 및 이것의 분자 클로닝 방법(hepatitis g virus and mo-lecular cloning thereof) | |
| Loeber et al. | Temperature-sensitive mutants identify crucial structural regions of simian virus 40 large T antigen | |
| JPH09501568A (ja) | 腫瘍サプレッサ蛋白質prb2、関連遺伝子産生物およびそれをコードするdna | |
| JP3140773B2 (ja) | ウイルスの検出に関する改良 | |
| US20070092936A1 (en) | Severe acute respiratory syndrome | |
| Davies et al. | Definition of murine T helper cell determinants in the major capsid protein of human papillomavirus type 16 | |
| WO2012089742A2 (en) | IDENTIFICATION OF A NOVEL HUMAN POLYOMAVIRUS (IPPyV) AND APPLICATIONS | |
| US6413522B1 (en) | Papilloma viruses, products for the detection thereof as well as for treating diseases caused by them | |
| US6610303B1 (en) | Papilloma viruses, products for the detection thereof as well as for treating diseases caused by them | |
| US7105165B2 (en) | Mutant human hepatitis B viral strain and uses thereof | |
| Pelletier et al. | Characterization of the poliovirus 147S particle: new insights into poliovirus uncoating | |
| CA1341100C (en) | Determined dna sequences derived from a papilloma virus genome, their uses for in vitro diagnostic purposes and the production of antigenic compositions | |
| JPH02500326A (ja) | ヒトb親リンパ性ウイルス(hblv)の分子クローニング及びクローン類 | |
| Susloparov et al. | Recombinant Antigens of the Epstein-Barr Virus: Design and Investigation of Immunochemical Characteristics | 
Legal Events
| Date | Code | Title | Description | 
|---|---|---|---|
| PA0109 | Patent application | 
             Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 19871120  | 
        |
| PG1501 | Laying open of application | ||
| A201 | Request for examination | ||
| PA0201 | Request for examination | 
             Patent event code: PA02012R01D Patent event date: 19900629 Comment text: Request for Examination of Application Patent event code: PA02011R01I Patent event date: 19871120 Comment text: Patent Application  | 
        |
| E902 | Notification of reason for refusal | ||
| PE0902 | Notice of grounds for rejection | 
             Comment text: Notification of reason for refusal Patent event date: 19920922 Patent event code: PE09021S01D  | 
        |
| G160 | Decision to publish patent application | ||
| PG1605 | Publication of application before grant of patent | 
             Comment text: Decision on Publication of Application Patent event code: PG16051S01I Patent event date: 19930721  | 
        |
| E701 | Decision to grant or registration of patent right | ||
| PE0701 | Decision of registration | 
             Patent event code: PE07011S01D Comment text: Decision to Grant Registration Patent event date: 19931019  | 
        |
| GRNT | Written decision to grant | ||
| PR0701 | Registration of establishment | 
             Comment text: Registration of Establishment Patent event date: 19940112 Patent event code: PR07011E01D  | 
        |
| PR1002 | Payment of registration fee | 
             Payment date: 19940112 End annual number: 3 Start annual number: 1  | 
        |
| PR1001 | Payment of annual fee | 
             Payment date: 19960828 Start annual number: 4 End annual number: 4  | 
        |
| PR1001 | Payment of annual fee | 
             Payment date: 19970725 Start annual number: 5 End annual number: 5  | 
        |
| PR1001 | Payment of annual fee | 
             Payment date: 19980724 Start annual number: 6 End annual number: 6  | 
        |
| PR1001 | Payment of annual fee | 
             Payment date: 19990727 Start annual number: 7 End annual number: 7  | 
        |
| PR1001 | Payment of annual fee | 
             Payment date: 20000715 Start annual number: 8 End annual number: 8  | 
        |
| PR1001 | Payment of annual fee | 
             Payment date: 20010719 Start annual number: 9 End annual number: 9  | 
        |
| PR1001 | Payment of annual fee | 
             Payment date: 20020718 Start annual number: 10 End annual number: 10  | 
        |
| PR1001 | Payment of annual fee | 
             Payment date: 20030807 Start annual number: 11 End annual number: 11  | 
        |
| PR1001 | Payment of annual fee | 
             Payment date: 20040714 Start annual number: 12 End annual number: 12  | 
        |
| PR1001 | Payment of annual fee | 
             Payment date: 20050708 Start annual number: 13 End annual number: 13  | 
        |
| FPAY | Annual fee payment | 
             Payment date: 20060710 Year of fee payment: 14  | 
        |
| PR1001 | Payment of annual fee | 
             Payment date: 20060710 Start annual number: 14 End annual number: 14  | 
        |
| EXPY | Expiration of term | ||
| PC1801 | Expiration of term |